This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.20% per year. These returns cover a period from January 1, 1988 through April 1, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Zacks News
The Duckhorn Portfolio, Inc. (NAPA) Beats Q3 Earnings and Revenue Estimates
by Zacks Equity Research
The Duckhorn Portfolio, Inc. (NAPA) delivered earnings and revenue surprises of 30.77% and 8.34%, respectively, for the quarter ended April 2022. Do the numbers hold clues to what lies ahead for the stock?
HEINY vs. NAPA: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
HEINY vs. NAPA: Which Stock Is the Better Value Option?
Energizer (ENR) Beats on Q2 Earnings, Raises FY22 Sales View
by Zacks Equity Research
Solid performance across the auto care business boosts Energizer's (ENR) second-quarter fiscal 2022 sales results. Management repeats its EPS outlook for the current fiscal year.
Archer Daniels (ADM) Displays Strength: Stock Rally to Continue
by Zacks Equity Research
Archer Daniels (ADM) continues to gain from robust demand, product innovation, strength in the Nutrition segment and improved productivity.
Best Defensive Stocks to Buy
by David Bartosiak
With volatility spiking and stocks falling, these are some great stocks to buy to save your portfolio.
Monster Beverage (MNST) Q1 Earnings Miss, Sales Top Estimates
by Zacks Equity Research
Monster Beverage (MNST) reports a strong top line in Q1 on continued demand for energy drinks and growth across segments. Higher freight, fuel and distribution expenses hurt earnings.
AB InBev (BUD) Surpasses Sales & Earnings Estimates in Q1
by Zacks Equity Research
AB InBev's (BUD) Q1 results reflect continued business momentum, owing to relentless execution, investment in its brands and accelerated digital transformation.
Albertsons (ACI), Uber Extend Deal to Expedite Grocery Delivery
by Zacks Equity Research
In a bid to offer better and faster delivery, Albertsons (ACI) adds 800 stores to Uber Eats by expanding its partnership with Uber.
Molson Coors (TAP) Q1 Earnings & Sales Surpass Estimates
by Zacks Equity Research
Molson Coors' (TAP) Q1 results reflect continued progress on its revitalization plan, premiumization efforts and strength in core brands. However, inflationary pressure remains concerning.
FEMSA (FMX) Q1 Earnings Lag Estimates, Revenues Surpass
by Zacks Equity Research
FEMSA's (FMX) Q1 results reflect top-line and operating margin gains, driven by growth across all segments. The gross margin reflects a contraction at Coca-Cola FEMSA and FEMSA's Fuel operations.
Clorox (CLX) Q3 Earnings & Sales Beat on Solid Demand
by Zacks Equity Research
Clorox (CLX) Q3 results gained from solid demand, pricing actions and cost savings efforts. However, the ongoing inflationary pressures led to lowered bottom line view for fiscal 2022.
KNBWY vs. NAPA: Which Stock Is the Better Value Option?
by Zacks Equity Research
KNBWY vs. NAPA: Which Stock Is the Better Value Option?
Newell (NWL) Surpasses Earnings & Sales Estimates in Q1
by Zacks Equity Research
Newell's (NWL) Q1 results reflect gains from strong demand, solid core sales growth and FUEL productivity savings. Inflationary costs and supply-chain conditions remain headwinds.
Church & Dwight (CHD) Q1 Earnings & Sales Beat on Solid Demand
by Zacks Equity Research
Church & Dwight's (CHD) first-quarter 2022 performance reflects robust consumption for the company's brands. However, supply-chain issues and rising inflation remain concerning.
Archer Daniels (ADM) Rises on Q1 Earnings & Revenue Beat
by Zacks Equity Research
Archer Daniels' (ADM) Q1 results reflect gains from healthy product demand and strength in the Nutrition segment. However, reduced crop supplies have been a drag.
PepsiCo (PEP) Tops Q1 Earnings & Revenue Estimates, Ups View
by Zacks Equity Research
PepsiCo (PEP) Q1 results reflect gains from strength in global beverage and convenient food businesses. Strong volume growth pricing boosts the top line.
Coca-Cola's (KO) Earnings & Revenues Surpass Q1 Estimates
by Zacks Equity Research
Coca-Cola's (KO) Q1 results reflect gains from recovery across markets and strategic transformation. The company retains the 2022 view.
Boston Beer (SAM) Reports Q1 Loss, Misses Revenue Estimates
by Zacks Equity Research
Boston Beer (SAM) reports a loss per share and a revenue decline in Q1 on lower shipments and depletions, as well as margin contraction.
Can The Duckhorn Portfolio, Inc. (NAPA) Climb 31% to Reach the Level Wall Street Analysts Expect?
by Zacks Equity Research
The consensus price target hints at a 31.2% upside potential for The Duckhorn Portfolio, Inc. (NAPA). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
KNBWY vs. NAPA: Which Stock Is the Better Value Option?
by Zacks Equity Research
KNBWY vs. NAPA: Which Stock Is the Better Value Option?
Here's Why it is Appropriate to Own Diageo (DEO) Stock Now
by Zacks Equity Research
Diageo (DEO) witnesses recovery in the on-trade channel, strong consumer demand in off-trade and market share gains, which are likely to help it retain momentum.
KNBWY vs. NAPA: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
KNBWY vs. NAPA: Which Stock Is the Better Value Option?
Boston Beer (SAM) Down Above 10% on Slashed 2021 Earnings View
by Zacks Equity Research
Boston Beer (SAM) trims earnings view for 2021. Higher supply-chain expenses and reduced shipment volumes persist as headwinds.
Diageo (DEO) Looks Well-Positioned on Robust Demand Trends
by Zacks Equity Research
Diageo (DEO) is poised to benefit from improving consumer demand trends. Its efforts to expand the digital business and investments in RTDs bode well.
ABEV vs. NAPA: Which Stock Is the Better Value Option?
by Zacks Equity Research
ABEV vs. NAPA: Which Stock Is the Better Value Option?